First slide

OGT is excited to be participating in the Great Lakes Genomics Conference (GLGC). We would like to invite you to join our vendor presentation, Low-frequency SNV and structural aberration detection in hematological disorders, on Friday, May 15th at 2:20 PM (EST) to learn more about our SureSeq™ hematology NGS products.

During the presentation, OGT’s Head of Development, Dr. Jackie Chan, will discuss key features and benefits of the SureSeq NGS hematology range, including new CLL+CNV and pan-myeloid panels. Dr. Chan will conclude the session with a summary of SureSeq NGS pipeline products.